It’s not real. It’s just brick he posts on here that he would never dare say to anyone in real life.
If you knew what a lot of people thought of me you'd know otherwise.
It’s not real. It’s just brick he posts on here that he would never dare say to anyone in real life.
It the correct response!Honestly, don’t waste your time. It’s not even high level.
View attachment 11393
Who runs the site? Who benefits from plenty of visitors posting?
Nice conspiracy theory, but it doesn't pass a sense check.Honestly, don’t waste your time. It’s not even high level.
View attachment 11393
Who runs the site? Who benefits from plenty of visitors posting?
Thought you were talking about people.....?How do you value things if not by what they do for you?
Something you're an expert in, judging by today's posts.That would be a very inefficient use of my time
We all need time for entertainment.Something you're an expert in, judging by today's posts.
If something isn't a thing it's literally nothing.Thought you were talking about people.....?
ahh that's right ....'things'
I had to do a double-take on this. How many lives is your 'freedom' worth, just to put a figure on it?
(edit : I've just noticed we're on page 666...fancy that)
Thankfully I have a different value system to you. One where my relationship to other people is not viewed transactionally or through a monetary lens.How do you value things if not by what they do for you?
Depends on the worth of any of those people to me.
For example, a good chef whose restaurant I like would have high value. The person who irons our clothes and the ones who clean my car - all valuable.
Someone in Rotherham who I don't even know exists - meh.
Nice conspiracy theory, but it doesn't pass a sense check.
If I doubled the number of visitors to this site it would make less in a month than an hour of my time is worth. That would be a very inefficient use of my time.
I wonder how they go about introducing additional vaccines such as this given the logistics of the second doses. Does it go nationwide with the associated jeopardy of matching people up again to each particular vaccine for dose 2.
I would assume it would be introduced only for new first dose appointments, but you never know nowadays. Could be just as likely that we run out of one and they have to scramble together a press release that mixing and matching is perfectly fine!
Thanks for posting Steve, really interesting.Way ahead of you...
https://www.nihr.ac.uk/news/worlds-...e-alternating-dose-study-launches-in-uk/26773
The world’s first COVID-19 vaccine study researching alternating doses of two approved vaccines - alongside different dosing intervals, begins today (February 4th) at eight research sites across England.
The National Institute for Health Research (NIHR) supported study, referred to as the COVID-19 Heterologous Prime Boost study, or ‘Com-Cov’, will determine the effects of using a different approved vaccine for the second dose to the first dose, in addition to examining the efficacy of two different time intervals between doses.
Over 800 volunteers, aged 50-years-old and above, are expected to take part in the study at eight sites across England - including in Oxford, London, Birmingham, Liverpool, Nottingham, Bristol and Southampton.
https://www.nature.com/articles/d41586-021-00315-5
Vaccine developers often combine two vaccines to combat the same pathogen, and researchers are keen to deploy the strategy — known as a heterologous prime-boost — against the coronavirus. A heterologous prime-boost combination was approved last year by European regulators to protect against Ebola, and experimental HIV vaccines often rely on the strategy
Way ahead of you...
https://www.nihr.ac.uk/news/worlds-...e-alternating-dose-study-launches-in-uk/26773
The world’s first COVID-19 vaccine study researching alternating doses of two approved vaccines - alongside different dosing intervals, begins today (February 4th) at eight research sites across England.
The National Institute for Health Research (NIHR) supported study, referred to as the COVID-19 Heterologous Prime Boost study, or ‘Com-Cov’, will determine the effects of using a different approved vaccine for the second dose to the first dose, in addition to examining the efficacy of two different time intervals between doses.
Over 800 volunteers, aged 50-years-old and above, are expected to take part in the study at eight sites across England - including in Oxford, London, Birmingham, Liverpool, Nottingham, Bristol and Southampton.
https://www.nature.com/articles/d41586-021-00315-5
Vaccine developers often combine two vaccines to combat the same pathogen, and researchers are keen to deploy the strategy — known as a heterologous prime-boost — against the coronavirus. A heterologous prime-boost combination was approved last year by European regulators to protect against Ebola, and experimental HIV vaccines often rely on the strategy
What about people you don't even know exist? What happens the moment they snuff out of existence, other than your heart taking another beat?Thankfully I have a different value system to you. One where my relationship to other people is not viewed transactionally or through a monetary lens.